SCHEMBL16218784

SCHEMBL16218784

FCCc1cn(Cc2cccc(Cl)c2)nn1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.60
CYP19A1 P11511 6/20 0.54
HSP90AB1 P08238 1/20 0.49
NOTUM Q6P988 1/20 0.48
JAK2 O60674 1/20 0.46
ROCK2 O75116 1/20 0.46
KDR P35968 1/20 0.46
GSK3B P49841 1/20 0.46
AURKB Q96GD4 1/20 0.46
KCNMA1 Q12791 1/20 0.46
MGAM O43451 1/20 0.46
GAA P10253 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
HDAC1 Q13547 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21557005 0.92 TYR (0.58) TYRCYP19A1HSP90AB1NOTUMHDAC1
SCHEMBL16219151 0.86 TYR (0.60) TYRCYP19A1HSP90AB1NOTUMJAK2
SCHEMBL16216237 0.86 CYP19A1 (0.74) TYRCYP19A1HSP90AB1NOTUMJAK2
SCHEMBL16401421 0.80 TYR (0.59) TYRCYP19A1NOTUMJAK2ROCK2
SCHEMBL30657567 0.75 CYP19A1 (0.72) CYP19A1HSP90AB1HDAC1NPC1RAB9A
SCHEMBL16219152 0.73 TYR (0.52) TYRCYP19A1NOTUMJAK2ROCK2
SCHEMBL15795458 0.73 CYP19A1 (0.71) CYP19A1HSP90AB1HDAC1NPC1RAB9A
SCHEMBL2194279 0.72 CYP19A1 (0.77) CYP19A1HSP90AB1HDAC1NPC1RAB9A
SCHEMBL16206208 0.72 CYP19A1 (0.82) CYP19A1HSP90AB1HDAC1NPC1RAB9A
SCHEMBL10660863 0.72 TYR (0.54) TYRCYP19A1JAK2ROCK2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200397927-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS LANTHEUS MEDICAL IMAGING, INC. (US) 2020-12-24 US disclosed
EP-3567029-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS Lantheus Medical Imaging, Inc. (US) 2019-11-13 EP disclosed
US-20170266326-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS LANTHEUS MEDICAL IMAGING, INC. (US) 2017-09-21 US disclosed
US-9550000-B2 Compositions, methods, and systems for the synthesis and use of imaging agents LANTHEUS MEDICAL IMAGING, INC. (US) 2017-01-24 US disclosed
US-20140328756-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS LANTHEUS MEDICAL IMAGING, INC. (US) 2014-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170266326-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS FABP3, TNNI3, TNNT2 TYR 1231/4885CYP19A1 2566/4885HSP90AB1 1763/4885
US-20140328756-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS FABP3, TNNI3, TNNT2 TYR 1231/4885CYP19A1 2566/4885HSP90AB1 1763/4885
US-20200397927-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS FABP3, TNNI3, TNNT2 TYR 1231/4885CYP19A1 2566/4885HSP90AB1 1763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.